Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 66; no. 21; pp. 2362 - 2371
Main Authors Maron, Barry J, Udelson, James E, Bonow, Robert O, Nishimura, Rick A, Ackerman, Michael J, Estes, 3rd, N A Mark, Cooper, Jr, Leslie T, Link, Mark S, Maron, Martin S
Format Journal Article
LanguageEnglish
Published United States 01.12.2015
Subjects
Adolescent
Adult
Advisory Committees
American Heart Association
Arrhythmogenic Right Ventricular Dysplasia - complications
Arrhythmogenic Right Ventricular Dysplasia - diagnosis
Arrhythmogenic Right Ventricular Dysplasia - epidemiology
Athletes
Cardiology - standards
Cardiomyopathies - complications
Cardiomyopathies - diagnosis
Cardiomyopathies - epidemiology
Cardiomyopathy, Hypertrophic - complications
Cardiomyopathy, Hypertrophic - diagnosis
Cardiomyopathy, Hypertrophic - epidemiology
Cardiovascular Abnormalities - complications
Cardiovascular Abnormalities - diagnosis
Cardiovascular Abnormalities - epidemiology
Child
Female
Humans
Male
Myocarditis - complications
Myocarditis - diagnosis
Myocarditis - epidemiology
Practice Guidelines as Topic - standards
United States - epidemiology
Young Adult
United States
ACC/AHA Scientific Statements
sudden death
myocarditis
arrhythmogenic right ventricular cardiomyopathy
cardiovascular abnormalities
athletes
hypertrophic cardiomyopathy
cardiomyopathy
cardiovascular magnetic resonance
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1558-3597
DOI:10.1016/j.jacc.2015.09.035